Scienture Holdings, Inc. (NASDAQ:SCNX) Short Interest Update

Scienture Holdings, Inc. (NASDAQ:SCNX) was the recipient of a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 3,504,653 shares, a growth of 46.2% from the December 31st total of 2,397,102 shares. Based on an average trading volume of 2,225,372 shares, the short-interest ratio is presently 1.6 days. Currently, 11.0% of the shares of the company are sold short. Currently, 11.0% of the shares of the company are sold short. Based on an average trading volume of 2,225,372 shares, the short-interest ratio is presently 1.6 days.

Analysts Set New Price Targets

Several brokerages have recently weighed in on SCNX. Weiss Ratings reissued a “sell (e+)” rating on shares of Scienture in a report on Monday, December 29th. Wall Street Zen cut Scienture from a “hold” rating to a “sell” rating in a research report on Sunday, January 25th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Scienture currently has a consensus rating of “Sell”.

Scienture Price Performance

Scienture stock opened at $0.45 on Friday. The business has a 50 day simple moving average of $0.54 and a 200 day simple moving average of $0.94. The company has a market capitalization of $18.46 million, a PE ratio of -0.45 and a beta of 3.00. Scienture has a one year low of $0.45 and a one year high of $3.90.

Scienture (NASDAQ:SCNX) last announced its quarterly earnings results on Wednesday, November 12th. The company reported ($0.19) earnings per share for the quarter. The business had revenue of $0.59 million during the quarter.

About Scienture

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.